Skip Navigation

Europace 2005 7(3):266-272; doi:10.1016/j.eupc.2005.01.006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Plummer, C. J.
Right arrow Articles by McComb, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plummer, C. J.
Right arrow Articles by McComb, J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved.

The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district*

Christopher J. Plummer*, R. John Irving and Janet M. McComb

Department of Cardiology, Newcastle upon Tyne Hospitals NHS trust, Freeman Hospital Newcastle upon Tyne NE7 7DN, UK

AIMS: Implantable cardioverter defibrillators (ICDs) have been shown to reduce all-cause mortality in groups of patients at high risk of ventricular arrhythmias. The true incidence of ICD indications is unknown but we hypothesize that it far exceeds the number actually implanted.

METHODS: In a one month observational audit, we reviewed the clinical records of all 336 patients admitted to coronary care units serving a district with a population of 471,000, to determine the additional screening tests required in myocardial infarction (MI) survivors and the number of additional ICDs which would be implanted for the primary and secondary prevention indications recommended in UK National Institute for Clinical Excellence (NICE) guidance. A further analysis was performed to determine the effect of extending the primary prevention indications to include the selection criteria used in the second multicentre automatic defibrillator trial, MADIT II.

RESULTS: Using NICE criteria, we found the incidence of ICD indications to be 98.4/106/year. The addition of patients fulfilling MADIT II selection criteria for primary prevention would have increased this to 453/106/year.

CONCLUSION: We conclude that the implementation of national guidance on the use of ICDs for arrhythmias will require the systematic screening of MI survivors, and would identify an incidence of ICD indications at least three times that anticipated by NICE, and eight times as many as were actually implanted in the UK in 2000. If the primary prevention indications were widened to include MADIT II selection criteria, the total would be nearer to 12 times that anticipated, and 47 times the number actually implanted.

Key Words: implantable cardioverter defibrillators (ICDs), guidelines, audit

*Corresponding author. Department of Cardiology, Newcastle upon Tyne Hospitals NHS Trust, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK. Tel.: +44 191 233 6161; fax: +44 191 213 0498.E-mail address: c.j.plummer{at}ncl.ac.uk (C.J. Plummer).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
P.A. Scott, S. Gorman, N.P. Andrews, P.R. Roberts, and P.R. Kalra
Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006)
Europace, April 1, 2008; 10(4): 453 - 457.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.